טוען...
(18)F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer
Changes in tumor metabolic activity have been shown to be an early indicator of treatment effectiveness for breast cancer, mainly in the neoadjuvant setting. The histopathologic response at the completion of chemotherapy has been used as the reference standard for assessment of the accuracy of (18)F...
שמור ב:
| הוצא לאור ב: | J Nucl Med |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5228521/ https://ncbi.nlm.nih.gov/pubmed/26834099 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.115.157875 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|